Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: A Study of HQP1351 in Patients With GIST or Other Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of HQP1351 in patients with Gastrointestinal stromal tumor and other solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HQP1351

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Adult | Phase 1 | Status: RECRUITING